Bacterial Respiratory Infections in Horses: Etiology, Clinical Signs, Diagnosis, and Treatment
Introduction
Bacterial respiratory infections represent a significant cause of morbidity and mortality in equine populations worldwide. These infections can affect both the upper and lower respiratory tracts, leading to conditions ranging from mild rhinitis to severe, life-threatening pneumonia and pleuropneumonia. The equine respiratory system is continuously exposed to environmental pathogens, and disease occurs when host defenses are compromised by stress, viral infection, transportation, or poor ventilation. Understanding the etiology, clinical presentation, diagnostic approaches, and treatment strategies for these infections is essential for effective clinical management and disease control in horses.
Etiology of Horse Bacterial Respiratory Infection
The etiology of horse bacterial respiratory infection is diverse, involving both primary and opportunistic bacterial pathogens. The most clinically significant organisms are discussed below.
Streptococcus equi subsp. equi
Streptococcus equi subsp. equi is the causative agent of strangles, one of the most common and highly contagious bacterial respiratory diseases of horses. This Gram-positive coccus is host-adapted to equids and is transmitted via direct contact or fomites. The bacterium colonizes the upper respiratory tract, particularly the tonsils and lymph nodes of the head and neck, where it induces a pronounced suppurative inflammatory response. The organism produces a hyaluronic acid capsule that inhibits phagocytosis and secretes several virulence factors, including streptolysin S and streptokinase, which contribute to tissue necrosis and abscess formation.
Streptococcus equi subsp. zooepidemicus
Streptococcus equi subsp. zooepidemicus is a common commensal of the equine upper respiratory tract but can act as an opportunistic pathogen. It is frequently isolated from cases of pneumonia, pleuropneumonia, and uterine infections in mares. This subspecies is also associated with respiratory disease in other species, including poultry, as discussed in the article on Streptococcus zooepidemicus Bacterial Infection in Poultry. In horses, it is often isolated in mixed infections following viral respiratory disease or stress-induced immunosuppression.
Rhodococcus equi
Rhodococcus equi is a Gram-positive, facultative intracellular coccobacillus and a major cause of bronchopneumonia in foals between 1 and 6 months of age. The organism is ubiquitous in soil and is acquired by inhalation of dust contaminated with feces from adult horses. Virulent strains harbor a plasmid encoding the virulence-associated protein A (VapA), which is essential for survival within macrophages. The bacterium inhibits phagosome-lysosome fusion and replicates within alveolar macrophages, leading to pyogranulomatous inflammation and abscess formation in the lungs.
Pasteurella multocida
Pasteurella multocida is a Gram-negative coccobacillus that is part of the normal flora of the equine upper respiratory tract but can cause secondary pneumonia, particularly in stressed or immunocompromised animals. It is more commonly associated with respiratory disease in other livestock species, such as fowl cholera in poultry, as detailed in the article on Fowl Cholera in Poultry. In horses, it is often isolated in conjunction with other bacteria in cases of bronchopneumonia.
Actinobacillus equuli
Actinobacillus equuli is a Gram-negative coccobacillus that is a normal inhabitant of the equine oral cavity and upper respiratory tract. It is a common cause of pneumonia and pleuropneumonia in adult horses, often following transportation or viral infection. The bacterium produces a polysaccharide capsule and endotoxin, which contribute to its pathogenicity. It is also a cause of neonatal septicemia and arthritis in foals.
Other Bacterial Pathogens
Other bacteria that can contribute to equine respiratory infections include Bordetella bronchiseptica, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and various anaerobic species such as Fusobacterium spp. and Bacteroides spp. Anaerobic bacteria are particularly important in cases of pleuropneumonia and pulmonary abscessation, where they contribute to the formation of foul-smelling exudate and necrotic tissue.
Clinical Signs
The clinical signs of horse bacterial respiratory infection vary depending on the etiologic agent, the site of infection, and the severity of disease.
Upper Respiratory Tract Infections
Infections of the upper respiratory tract, most notably strangles caused by S. equi subsp. equi, present with acute onset of fever (39.5 to 41.0 degrees Celsius), depression, anorexia, and a profuse, mucopurulent nasal discharge. Affected horses develop painful swelling and abscessation of the submandibular and retropharyngeal lymph nodes. These abscesses may rupture and drain externally. Dysphagia, cough, and stertorous breathing are common. Complications of strangles include guttural pouch empyema, purpura hemorrhagica, and metastatic abscessation (bastard strangles).
Lower Respiratory Tract Infections
Lower respiratory tract infections, including pneumonia and pleuropneumonia, present with fever, lethargy, anorexia, tachypnea, and a deep, productive cough. Horses may exhibit increased respiratory effort, nostril flaring, and abnormal lung sounds on auscultation, including crackles, wheezes, and areas of decreased breath sounds. Pleuropneumonia is characterized by pleural effusion, which can cause pleurodynia (chest pain), manifested as reluctance to move, elbow abduction, and a stilted gait. In severe cases, horses may develop systemic inflammatory response syndrome (SIRS) and septic shock.
Foal Pneumonia
Foals with R. equi pneumonia often present with a subacute to chronic course. Early signs include mild fever, tachypnea, and a soft cough. As the disease progresses, foals develop marked respiratory distress, mucopurulent nasal discharge, and weight loss. Abscessation of the lungs is a hallmark of the disease, and affected foals may have abnormal lung sounds on auscultation. Extrapulmonary manifestations, including septic arthritis, osteomyelitis, and diarrhea, are common.
Diagnosis
A definitive diagnosis of horse bacterial respiratory infection requires a combination of clinical examination, diagnostic imaging, laboratory testing, and microbiological culture.
Clinical Examination and History
A thorough history, including recent transportation, exposure to other horses, vaccination status, and onset of clinical signs, is essential. Physical examination should include assessment of body temperature, respiratory rate and effort, auscultation of the trachea and lungs, and palpation of the submandibular and retropharyngeal lymph nodes.
Diagnostic Imaging
Thoracic radiography is a valuable tool for evaluating the lower respiratory tract. In cases of pneumonia, radiographs may reveal alveolar, interstitial, or bronchial patterns, as well as pulmonary abscesses. Pleuropneumonia is characterized by pleural effusion, which appears as a soft tissue opacity obscuring the cardiac silhouette and diaphragm. Thoracic ultrasonography is superior for detecting pleural effusion, pulmonary abscesses, and consolidations, and it can guide thoracocentesis.
Endoscopy
Endoscopic examination of the upper and lower respiratory tract allows direct visualization of the mucosa, collection of samples for culture and cytology, and assessment of guttural pouches. Tracheal wash and bronchoalveolar lavage (BAL) are commonly performed to obtain samples for cytology and microbiological culture.
Microbiological Culture and Sensitivity
Definitive diagnosis relies on the isolation and identification of the causative bacterium from clinical samples. Samples include nasal swabs, nasopharyngeal swabs, tracheal wash fluid, BAL fluid, pleural fluid, and abscess contents. Samples should be collected aseptically and submitted for aerobic and anaerobic culture. Antimicrobial susceptibility testing is critical for guiding treatment, particularly given the increasing prevalence of antimicrobial resistance.
Molecular Diagnostics
Polymerase chain reaction (PCR) assays are available for the rapid detection of specific pathogens, including S. equi subsp. equi and R. equi. Real-time PCR assays offer high sensitivity and specificity and can provide results within hours, facilitating early diagnosis and implementation of control measures.
Hematology and Serum Biochemistry
Hematological findings in bacterial respiratory infections typically include leukocytosis with neutrophilia and hyperfibrinogenemia. In severe cases, leukopenia may be observed. Serum biochemistry may reveal elevated acute phase proteins, such as serum amyloid A (SAA), which is a sensitive marker of inflammation and infection.
flowchart TD
A[Clinical Signs: Fever, Cough, Nasal Discharge, Dyspnea], > B[Physical Examination]
B, > C{Upper or Lower Respiratory Tract?}
C, >|Upper| D[Endoscopy + Nasal/Nasopharyngeal Swab]
C, >|Lower| E[Thoracic Radiography/Ultrasonography]
D, > F[Microbiological Culture + PCR]
E, > G[Tracheal Wash / Bronchoalveolar Lavage]
G, > F
F, > H[Antimicrobial Susceptibility Testing]
H, > I[Targeted Antimicrobial Therapy]
I, > J[Monitor Clinical Response + Repeat Diagnostics if Needed]
Treatment
Treatment of horse bacterial respiratory infection is based on appropriate antimicrobial therapy, supportive care, and management of complications.
Antimicrobial Therapy
Selection of antimicrobial agents should be guided by culture and sensitivity results. Empirical therapy is often initiated while awaiting laboratory results, based on the most likely pathogen and local resistance patterns.
For S. equi subsp. equi infections, penicillin G (22,000 IU/kg intravenously every 6 hours) is the drug of choice. Procaine penicillin G (22,000 IU/kg intramuscularly every 12 hours) is an alternative for less severe cases. For S. equi subsp. zooepidemicus, penicillin is also effective, although resistance has been reported.
For R. equi pneumonia, combination therapy with a macrolide (erythromycin or azithromycin) and rifampin is the standard of care. Azithromycin (10 mg/kg orally every 24 hours) and rifampin (5 mg/kg orally every 12 hours) are commonly used. Clarithromycin (7.5 mg/kg orally every 12 hours) is an alternative macrolide.
For Gram-negative infections, including those caused by P. multocida and A. equuli, potentiated sulfonamides (trimethoprim-sulfamethoxazole, 30 mg/kg orally every 12 hours) or ceftiofur (2.2 mg/kg intramuscularly every 12 hours) are often effective. For severe cases, aminoglycosides (gentamicin, 6.6 mg/kg intravenously every 24 hours) may be added, but careful monitoring of renal function is required.
For anaerobic infections, metronidazole (15 mg/kg orally every 6 to 8 hours) is the drug of choice.
Supportive Care
Supportive care is critical for recovery. Nonsteroidal anti-inflammatory drugs (NSAIDs), such as flunixin meglumine (1.1 mg/kg intravenously every 12 to 24 hours), are used to reduce fever and inflammation. Fluid therapy is indicated for dehydrated or septic horses. In cases of pleuropneumonia, thoracocentesis and chest tube drainage are often necessary to remove purulent pleural fluid and relieve respiratory compromise.
Management of Strangles
For strangles, the primary goal is to promote abscess maturation and drainage. Hot packing of swollen lymph nodes can accelerate abscess formation. Once abscesses have matured, they should be lanced and drained. NSAIDs are used for fever and pain. Antimicrobial therapy is controversial in uncomplicated cases, as it may delay the development of immunity and increase the risk of metastatic abscessation. However, antimicrobials are indicated in severe cases, in horses with respiratory compromise, or when complications such as guttural pouch empyema are present.
Control and Prevention
Control of horse bacterial respiratory infection relies on biosecurity, vaccination, and management practices.
Biosecurity
Isolation of affected horses is essential to prevent the spread of contagious pathogens, particularly S. equi subsp. equi. New arrivals should be quarantined for at least 2 to 3 weeks. Shared equipment, water sources, and feeding utensils should be disinfected. Personnel should practice good hygiene, including hand washing and changing clothing between handling affected and unaffected horses.
Vaccination
Vaccines are available for strangles, including both intramuscular and intranasal formulations. These vaccines reduce the severity of disease but do not provide complete protection. No commercially available vaccines are widely used for other bacterial respiratory pathogens in horses, although autogenous vaccines may be considered in some situations.
Environmental Management
Good ventilation in stables reduces the concentration of airborne pathogens and irritants. Reducing dust and ammonia levels is important for maintaining respiratory health. Minimizing stress, avoiding overcrowding, and ensuring adequate nutrition support immune function.
Conclusion
Bacterial respiratory infections in horses are caused by a diverse range of pathogens, with S. equi subsp. equi, S. equi subsp. zooepidemicus, R. equi, P. multocida, and A. equuli being the most clinically significant. Accurate diagnosis requires a combination of clinical examination, imaging, and microbiological testing. Treatment is based on targeted antimicrobial therapy and supportive care. Control measures include biosecurity, vaccination, and environmental management. A thorough understanding of the etiology and pathogenesis of these infections is essential for effective clinical management and prevention.
References
- Sweeney, C.R., Timoney, J.F., Newton, J.R., and Hines, M.T. (2005). Streptococcus equi infections in horses: guidelines for treatment, control, and prevention of strangles. Journal of Veterinary Internal Medicine, 19(1), 123-134.
- Giguère, S., Cohen, N.D., Chaffin, M.K., and Slovis, N.M. (2011). Rhodococcus equi: clinical manifestations, virulence, and immunity. Journal of Veterinary Internal Medicine, 25(6), 1221-1230.
- Lavoie, J.P., and Hinchcliff, K.W. (2014). Equine Respiratory Medicine and Surgery. Saunders Elsevier.
- Reed, S.M., Bayly, W.M., and Sellon, D.C. (2010). Equine Internal Medicine. Saunders Elsevier.
- Ainsworth, D.M., and Hackett, R.P. (2004). Bacterial pneumonia and pleuropneumonia in adult horses. Veterinary Clinics of North America: Equine Practice, 20(1), 1-20.
- Timoney, J.F. (2004). The pathogenic equine streptococci. Veterinary Research, 35(4), 397-409.
- Giguère, S., and Prescott, J.F. (1997). Clinical manifestations, diagnosis, treatment, and prevention of Rhodococcus equi infections in foals. Veterinary Microbiology, 56(3-4), 313-334.
- Boyle, A.G., and Sweeney, C.R. (2006). Streptococcus equi subsp. equi infection (strangles) in horses. Compendium on Continuing Education for the Practicing Veterinarian, 28(6), 452-462.
- Robinson, N.E., and Furlow, P.W. (2007). Current Therapy in Equine Medicine. Saunders Elsevier.
- Sellon, D.C., and Long, M.T. (2014). Equine Infectious Diseases. Saunders Elsevier.
Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.